Neurological and neurodevelopmental effects of Covid and MIS-C on children

Area of Science:

• Pediatric Neurology
• Infectious Diseases
• Neurodevelopmental Disorders

Background:

• The pediatric population exhibits unique disease phenotypes from SARS-CoV-2, including Multisystem Inflammatory Syndrome in Children (MIS-C) and PIMS-TS.
• Neurological symptoms have been increasingly reported in children infected with SARS-CoV-2.
• The long-term neurological and neurodevelopmental consequences of SARS-CoV-2 infection and MIS-C/PIMS-TS in children remain poorly understood.

Purpose of the Study:

• To review current knowledge on the neurological and neurodevelopmental effects of SARS-CoV-2 and MIS-C in children.
• To emphasize the potential direct impact of SARS-CoV-2 and MIS-C on neurological and neurodevelopmental outcomes in pediatric patients.
• To highlight the need for further research into the pathophysiology and neurovirulence of SARS-CoV-2.

Main Methods:

• Comprehensive literature review of studies on pediatric neurological sequelae of SARS-CoV-2.
• Analysis of reported cases of neurological symptoms associated with acute SARS-CoV-2 infection and MIS-C/PIMS-TS.
• Synthesis of current understanding regarding the neurodevelopmental outcomes in affected children.

Main Results:

• Neurological symptoms are a recognized manifestation of SARS-CoV-2 in children.
• MIS-C/PIMS-TS can present with significant neurological and neurodevelopmental complications.
• The direct neurovirulence of SARS-CoV-2 in the pediatric population requires further investigation.

Conclusions:

• Acknowledging the potential direct neurological effects of SARS-CoV-2 and MIS-C is critical for pediatric care.
• Long-term follow-up studies are essential to fully understand the neurodevelopmental sequelae in children.
• Increased research is needed to elucidate the mechanisms underlying SARS-CoV-2-related neurological conditions in children.